J-GLOBAL ID：201601012612731839
Update date: Mar. 18, 2024
Uenaka Takeshi
Uenaka Takeshi
Research field (1)：
Neurology
Research theme for competitive and other funds (1)：
2019 - 2021 Drug repositioningによるアルファシヌクレイン凝集抑制薬の探索
Papers (14)：
Diane L Haakonsen, Michael Heider, Andrew J Ingersoll, Kayla Vodehnal, Samuel R Witus, Takeshi Uenaka, Marius Wernig, Michael Rapé. Stress response silencing by an E3 ligase mutated in neurodegeneration. Nature. 2024. 626. 8000. 874-880
Kelsie Eichel, Takeshi Uenaka, Vivek Belapurkar, Rui Lu, Shouqiang Cheng, Joseph S Pak, Caitlin A Taylor, Thomas C Südhof, Robert Malenka, Marius Wernig, et al. Endocytosis in the axon initial segment maintains neuronal polarity. Nature. 2022. 609. 7925. 128-135
Takeshi Uenaka, Wataru Satake, Pei-Chieng Cha, Hideki Hayakawa, Kousuke Baba, Shiying Jiang, Kazuhiro Kobayashi, Motoi Kanagawa, Yukinori Okada, Hideki Mochizuki, et al. In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson's disease. Human molecular genetics. 2018. 27. 22. 3974-3985
T. Uenaka, W. Satake, C. P. Chieng, Y. Okada, T. Toda. In silico drug discovery for Parkinson's disease by using genome-wide association study (GWAS) data. MOVEMENT DISORDERS. 2015. 30. S51-S51
